Search Results
56 items found for "Miranda J Song"
- 📰 GPCR Weekly News, May 20 to 26, 2024
Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery Nicola J
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
transmembrane domains modulates holo-adhesion GPCR function Szymon P Kordon , Kristina Cechova , Sumit J
- 📰 GPCR Weekly News, September 18 to 24, 2023
Deadline September 27, 2023 GPCR Events, Meetings, and Webinars October 2 - 3, 2023 | Celebrating Robert J.
- 📰 GPCR Weekly News, September 11 to 17, 2023
: Allosteric Function and Biased Signaling" at the DOT NEW October 2 - 3, 2023 | Celebrating Robert J.
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease
- Odorant receptors – a bit of smell for drug discovery
molecules which initiate a neuronal response that drives odorant discrimination and perception (Young J. non-small-cell lung cancer OR2J3 activation induced apoptosis and inhibited cell proliferation and migration in long-term
- Unlocking the Future of Medicine: Advancements in GPCR Research
work on Conformational dynamics underlying atypical chemokine receptor 3 activation Michael Trogdon, J
- 📰 GPCR Weekly News, April 8 to 14, 2024
et al. for their study on Frizzleds act as dynamic pharmacological entities Marina Casiraghi, Robert J
- 📰 GPCR Weekly News, May 6 to 12, 2024
Chakit Arora, J Silvio Gutkind, and Francesco Raimondi for their work on The landscape of cancer-rewired
- Glyco-sulfo hotspots in the chemokine receptor system
N-termini that mediate ligand binding and signaling (Bannert N et al. 2001; Casarosa P et al. 2005; Gao J GSnP-6 displays nanomolar affinity and promising potential for blocking PSGL-1/P-selectin interaction (Wong
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
Artificial intelligence - Machine learning vs Deep Learning GPCRs have long been recognized as important predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong , 2016; Kuang, Feng, Hu, Wang, He & Kong, 2016). 5. ability of a ligand to induce or inhibit a cellular response (pEC50 or pIC50, respectively), and how long
- Reflections on My PhD Journey: Lessons Learned
Procrastination may seem tempting, but tackling your work incrementally will save time and reduce stress in the long The road may be long, and challenges will test your resolve, but every small victory along the way shapes
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
Our results reveal that the extended N-terminus of the long isoform limits G protein activation yet elevates constitutive G13 activation, while an additional cysteine contributed by the extended N-terminus of the long
- GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between ...
GPCRs have been long considered as controllers of communication between tissues and cells. receptorsomes, both at the cell surface membrane and in the intracellular domain dictate and condition long-term
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
Here, we investigate the effects that long-term CNO stimulatory culture have on hM3Dq [Ca2+]i signaling Long-term culturing under repeated CNO stimulation modified the temporal dynamics of hM3Dq [Ca2+]i signaling
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
adopted to elucidate the structure, pharmacology, and signaling of cardiovascular GPCRs, resolving long-standing
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
disease before they can even dare to contemplate the development of therapeutic options and begin the long
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
We show that besides classical hydrogen bonds, weak polar interactions such as O-HC, O-Br, and long-range
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
heterogeneous disease with few effective targeted therapies and precision therapeutic options over a long
- 📰 GPCR Weekly News, May 1 to 7, 2023
Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Award Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting
- 📰 GPCR Weekly News, September 4 to 10, 2023
pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines Severity of neurological long-COVID
- 📰 GPCR Weekly News
Research CPGL: Prediction of Compound-Protein Interaction by Integrating Graph Attention Network With Long
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
pain and chronic inflammation Developmental exposures to common environmental pollutants result in long-term
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Hormone-responsive ovarian steroidogenesis Cardiovascular Complications and Their Association With Short- and Long-Term
- Targeting Intracellular Allosteric Sites in GPCRs
and NAMs and thereby blocks the effects of positive and negative allosteric modulators (Rodriguez, Nong
- Structural landscape of the Chemokine Receptor system
interaction follows a common pattern which is generally described by the classic “two-site” model (Crump, Gong
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
This leads to strikingly long in vitro receptor occupancy durations (at least seven days), meaning that